Horizon Therapeutics Public Ltd Co

ROYAL BANK OF CANADA

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

27,155

Value ($000)

3,142

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	3,142	0.0%	27,155	9/30/2023
2023 Q2	8/14/2023	4,354	0.0%	42,336	6/30/2023
2023 Q1	5/15/2023	27,859	0.0%	255,272	3/31/2023
2022 Q4	2/14/2023	11,919	0.0%	104,736	12/31/2022
2022 Q3	11/14/2022	9,138	0.0%	147,655	9/30/2022
2022 Q2	8/15/2022	9,064	0.0%	113,631	6/30/2022
2022 Q1	5/16/2022	19,930	0.0%	189,437	3/31/2022
2021 Q4	2/14/2022	13,581	0.0%	126,040	12/31/2021
2021 Q3	11/15/2021	12,776	0.0%	116,634	9/30/2021
2021 Q2	8/16/2021	10,222	0.0%	109,174	6/30/2021
2021 Q1	7/20/2021	8,955	0.0%	97,300	3/31/2021
2020 Q4	2/16/2021	3,376	0.0%	46,148	12/31/2020
2020 Q3	11/16/2020	2,469	0.0%	31,770	9/30/2020
2020 Q2	8/14/2020	1,451	0.0%	26,119	6/30/2020
2020 Q1	6/16/2020	389	0.0%	13,141	3/31/2020
2019 Q4	2/14/2020	550	0.0%	15,200	12/31/2019